Exact Mass: 578.2297898
Exact Mass Matches: 578.2297898
Found 99 metabolites which its exact mass value is equals to given mass value 578.2297898
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
methyl 1alpha-acetoxy-2beta,3alpha,6,8alpha,14beta-pentahydroxy-[4.2.110,30.11,4]-tricyclomeliac-7-oate
phenethyl alcohol 8-O-beta-D-glucopyranosyl-(1->2)-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside
kansanoside A|phenylethyl-beta-D-glucopyranosyl-(1->2)-[beta-D-xylopyranosyl-(1->6)]-beta-D-galactopyranoside
3-O-methyl-21,23-dihydro-23-hydroxy-21-oxonomilinic acid
C29H38O12_Methyl 2-(hexopyranosyloxy)-4-({6-[2-(4-hydroxyphenyl)ethyl]-4-oxotetrahydro-2H-pyran-2-yl}methyl)-3-vinyl-3,4-dihydro-2H-pyran-5-carboxylate
Ala Tyr Tyr Tyr
Cys Asp Arg Trp
Cys Asp Trp Arg
Cys Phe Phe Tyr
Cys Phe Tyr Phe
Cys Arg Asp Trp
Cys Arg Trp Asp
Cys Trp Asp Arg
Cys Trp Arg Asp
Cys Tyr Phe Phe
Asp Cys Arg Trp
Asp Cys Trp Arg
Asp Arg Cys Trp
Asp Arg Trp Cys
Asp Trp Cys Arg
Asp Trp Arg Cys
Phe Cys Phe Tyr
Phe Cys Tyr Phe
Phe Phe Cys Tyr
Phe Phe Tyr Cys
Phe Ser Tyr Tyr
Phe Tyr Cys Phe
Phe Tyr Phe Cys
Phe Tyr Ser Tyr
Phe Tyr Tyr Ser
Gly Met Trp Trp
Gly Trp Met Trp
Gly Trp Trp Met
Met Gly Trp Trp
Met Trp Gly Trp
Met Trp Trp Gly
Arg Cys Asp Trp
Arg Cys Trp Asp
Arg Asp Cys Trp
Arg Asp Trp Cys
Arg Trp Cys Asp
Arg Trp Asp Cys
Ser Phe Tyr Tyr
Ser Tyr Phe Tyr
Ser Tyr Tyr Phe
Trp Cys Asp Arg
Trp Cys Arg Asp
Trp Asp Cys Arg
Trp Asp Arg Cys
Trp Gly Met Trp
Trp Gly Trp Met
Trp Met Gly Trp
Trp Met Trp Gly
Trp Arg Cys Asp
Trp Arg Asp Cys
Trp Trp Gly Met
Trp Trp Met Gly
Tyr Ala Tyr Tyr
Tyr Cys Phe Phe
Tyr Phe Cys Phe
Tyr Phe Phe Cys
Tyr Phe Ser Tyr
Tyr Phe Tyr Ser
Tyr Ser Phe Tyr
Tyr Ser Tyr Phe
Tyr Tyr Ala Tyr
Tyr Tyr Phe Ser
Tyr Tyr Ser Phe
Tyr Tyr Tyr Ala
Methyl 2-(hexopyranosyloxy)-4-({6-[2-(4-hydroxyphenyl)ethyl]-4-oxotetrahydro-2H-pyran-2-yl}methyl)-3-vinyl-3,4-dihydro-2H-pyran-5-carboxylate
sufentanil citrate
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics
Vardenafil HCl Trihydrate
D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058986 - Phosphodiesterase 5 Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor > C2127 - cGMP Phosphodiesterase Inhibitor D000089162 - Genitourinary Agents > D064804 - Urological Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
2-({6-[(3R)-3-{[3-(2-Cyanobenzyl)-1-methyl-2,6-dioxo-1,6-dihydro-4(2H)-pyrimidinyl]amino}-1-piperidinyl]-3-methyl-2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl}methyl)benzonitrile
2-[(2R,4aR,12aS)-5-methyl-8-[(4-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,4aR,12aR)-5-methyl-8-[(4-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2R,4aS,12aR)-5-methyl-8-[(4-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,4aS,12aS)-5-methyl-8-[(4-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,4aS,12aR)-5-methyl-8-[(4-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,4aR,12aS)-5-methyl-8-[(4-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2R,4aR,12aR)-5-methyl-8-[(4-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
Cyclo(Arg-Gly-Asp-D-Phe-Cys)
Cyclo(Arg-Gly-Asp-D-Phe-Cys) (Cyclo RGDfC), a cyclic RGD peptide which has high affinity to αvβ3, can disrupt cell integrin interactions. Cyclo(Arg-Gly-Asp-D-Phe-Cys) inhibits pluripotent marker expression in embryonic stem cells (ESCs) and the tumorigenic potential of mESCs in vivo. Cyclo(Arg-Gly-Asp-D-Phe-Cys) can be used in the research of tumors[1].